This story was first published in digitalhealth.net
ABPI to challenge NICE in court over new cost limits
The ABPI has applied for a Judicial Review over new procedures that restrict access to cost-effective medicines.
The Judicial Review has been applied for over the introduction by the National Institute for Health and Care Excellence (NICE) of an additional negotiation process for medicines that have already been assessed as cost-effective if there is a high chance that they will cost the NHS more than £20 million in the first three years of use. NICE’s own research shows that one in five new medicines will be affected.
The ABPI is also looking to reverse changes to the assessment of medicines for rare diseases, which it believes to be inappropriate and ineffective.
The new procedures have the potential to cause delays for patients waiting for treatment for a number of conditions including cancer, heart disease and diabetes. ABPI believes it should challenge these new procedures before the first medicines get caught in the system.
After raising concerns about the plans and offering to work on alternative proposals together, the ABPI is now seeking to challenge the NICE decisions in the courts.
Mike Thompson, chief executive of ABPI, said: “These new arrangements will delay access to cost-effective medicines and deny treatments to patients suffering from rare diseases. After many months of raising concerns with NICE, NHS England and the Department of Health and offering to work constructively on alternative proposals, we have applied to formally challenge these proposals in court.
"We believe this to be the right course of action due to the potential damage these changes will cause to NHS care and on our ability to research, develop and use new medicines here in the UK. We hope that the Government will reverse the changes and work with us to find a solution that works for everyone.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
